DMAC vs REG · $157.4M cap vs P/E 34, $12.93B cap
DiaMedica Therapeutics Inc (DMAC) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
DMAC does not have a complete income-statement cache yet.
REG does not have a complete income-statement cache yet.
DMAC currently screens at market cap $157.4M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the DMAC and REG stock pages for the full models.
Not investment advice.